Clinuvel Pharmaceuticals Limited (ASX: CUV) Share Price and News
() Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
Clinuvel Pharmaceuticals Limited (CUV) is a global biopharmaceutical company that develops drugs for the treatment of a range of skin disorders. The company’s flagship product is Scenesse, a drug designed for the treatment of erythropoietic protoporphyria (EPP). EPP is a rare metabolic disorder which causes burns after brief exposure to visible light, especially sunlight. It is estimated that there are 5,000 to 10,000 EPP patients worldwide.
Clinuvel is also seeking to progress the use of Scenesse for the treatment of vitiligo, a skin disorder characterised by the appearance of white to off-white skin patches due to the loss of melanin production.
The company’s history dates back to 1987 when university researchers devised an idea of synthesising human hormones to protect the skin. Clinuvel shares have been listed on the ASX since 2001 and as a biopharmaceutical company, the Clinuvel share price can often be particularly volatile, bouncing around in response to announcements such as clinical trials and new launches.
Clinuvel Pharmaceuticals Limited (ASX: CUV) Latest News
James Mickleboro | September 16, 2020 11:28am
Kogan.com Ltd (ASX:KGN) and SEEK Limited (ASX:SEK) shares are two of four charging notably higher on Wednesday. Here's why... More »
James Mickleboro | September 15, 2020 11:32am
Afterpay Ltd (ASX:APT) and Uniti Group Ltd (ASX:UWL) shares are two of four storming higher on Tuesday. Here's why... More »
James Mickleboro | September 15, 2020 10:26am
The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price is storming higher on Tuesday after the release of an announcement... More »
James Mickleboro | September 12, 2020 8:15am
Nufarm Limited (ASX:NUF) and Vocus Group Ltd (ASX:VOC) shares were among the best performers on the ASX 200 last week... More »
Ken Hall | September 11, 2020 9:11am
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is one to consider buying after jumping 9.2% higher on Thursday. More »
James Mickleboro | September 10, 2020 12:01pm
Afterpay Ltd (ASX:APT) and National Australia Bank Ltd (ASX:NAB) shares are making a splash on the ASX 200 on Thursday... More »
Will Clinuvel Pharmaceuticals pay a dividend in 2020?
Clinuvel Pharmaceuticals listed on the ASX in 2001 and only recently declared a profit for the first time in FY2017. Since then, the company went on to achieve increased profits across both FY2018 and FY2019. It also distributed final dividends of 2 cents and 2.5 cents per share for FY2018 and FY2019 respectively. As at 17 June 2020, Clinuvel has made no announcements regarding the status of its FY2020 dividend payment.
Does Clinuvel Pharmaceuticals offer a DRP?
Having only started paying dividends over the last couple of years, Clinuvel Pharmaceuticals does not currently offer a dividend reinvestment plan.